Effect of atorvastatin on low-density lipoprotein subfraction profile

Annals of Clinical Biochemistry

Volumn 36, Issue 2, 1999, Pages 240-241

  Landray, M J ^a   Hartland, A ^a   Hubscher, D ^a   Kendall, M J ^a   Cramb, R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atherogenic lipid profile; Electrophoresis; HMGCoA reductase inhibitors

Indexed keywords

ATORVASTATIN; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL;

EID: 0032975254     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329903600220     Document Type: Article

References (6)

1. Rajman I, Maxwell S, Cramb R, Kendall M. Particle size: The key to atherogenic lipoprotein? QJM 1994; 87: 709-20
2. Packard CJ. LDL subfractions and atherogenicity: An hypothesis from the University of Glasgow. Curr Med Res Opin 1996; 13: 379-90
3. Gaw A, Packard CJ, Caslake MJ, Griffin BA, Lindsay GM, Thomson J, et al. Effects of ciprofibrate on LDL metabolism in man. Atherosclerosis 1994; 108: 137-48
4. Shepherd J. Fibrates and statins in the treatment of hyperlipidaemia: An appraisal of their efficacy and safety. Eur Heart J 1995; 16: 5 13
5. Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, et al. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. JAMA 1996; 275: 128-33
6. Rajman I, Kendall MJ, Cramb R, Holder RL, Salih M, Gammage MD. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996; 125: 2311-242